Hepatitis in Delhi
India has one of the highest hepatitis B burdens in the world, with 40 million chronic carriers. Hepatitis C affects 6–12 million Indians. Both are leading causes of liver cirrhosis and cancer. At Dashvanth Healthcare Delhi, we provide comprehensive hepatitis screening and monitoring.
Hepatitis B Tests
- HBsAg: Active infection marker
- Anti-HBs: Immunity (from vaccination or past infection)
- HBeAg: High replication, high infectivity
- HBV DNA (viral load): Quantitative, monitors treatment
- LFT: Liver damage assessment
Hepatitis C Tests
- Anti-HCV Antibody: Screening test
- HCV RNA (PCR): Confirms active infection
- HCV Genotype: Guides treatment choice
Treatment
Hepatitis B
- Tenofovir or Entecavir (long-term antiviral therapy)
- Goal: Suppress viral load, prevent cirrhosis and liver cancer
Hepatitis C
- Direct-Acting Antivirals (DAAs) – Sofosbuvir combinations
- Cure rate >95% in 8–12 weeks
- Hepatitis C is now CURABLE
Hepatitis testing at Dashvanth Healthcare Delhi: 011-41670042.
